Activebkms-ef-eba5e329-5013-442d-b84b-f2c4f099f748

Discount Agreements for Denosumab (Biologics)

The Techniker Krankenkasse is entering into discount agreements for the active ingredient Denosumab through an open procedure. The goal is uniform conditions for up to 24 months, with contracts starting from 01.12.2025.

View original source

CONTRACTING AUTHORITY

Name

Techniker Krankenkasse

City

Hamburg

Country

Website

CLASSIFICATION

Procedure Type

Open Procedure

Contract Type

Supplies

Main CPV

33600000, Pharmaceutical products.

LOTS (2)

LOT-0001Supplies

Denosumab (60mg)

LOT-0002Supplies

Denosumab (120mg)

ADDITIONAL DETAILS

Legal Basis

32014L0024

DEADLINES & TIMELINE

Submission Deadline

11/30/202710:58 PM Uhr548 days remaining

(LOT-0001)

Published

05/25/2026

TENDER DOCUMENTS

548 days remaining

Similar Tenders

Explore CPV 33

Discount Agreements for Peginterferon beta 1a

The Techniker Krankenkasse is entering into discount agreements for Peginterferon beta 1a via an open-house procedure. The contracts will run for a maximum of 24 months starting August 1, 2026.

Techniker Krankenkasse

·Hamburg

Deadline:July 31, 2028

Discount Agreements for Denosumab (60mg) 2026

The Techniker Krankenkasse aims to conclude discount agreements for Denosumab (60mg) through its open-house procedure. The goal is to establish uniform conditions for a contract duration of up to 17 months.

Techniker Krankenkasse

·Hamburg

Deadline:November 30, 2027